September 10, 2024

FDA Grants Rare Pediatric Designation to Duchenne Drug

NS-050/NCNP-03 received rare pediatric disease designation for Duchenne muscular dystrophy.

Conexiant

September 09, 2024

FDA Lifts Hold on Low Blood Sugar Treatment

Rezolute Inc has received FDA approval to proceed with its late-stage trial for a new treatment addressing low blood sugar in individuals with congenital hyperinsulinism, with potential U.S. enrollment expected to start in early 2025.

Reuters

September 06, 2024

FDA Approves Ready-to-Use Version of Bortezomib for Subcutaneous Administration

The FDA has approved a new presentation of bortezomib (Boruzu) for ready-to-use subcutaneous or intravenous administration. This proteasome inhibitor is used for the treatment of multiple myeloma and ...

The ASCO Post

September 06, 2024

US Ramps Up Mpox Response Amid New Strain Concerns

Health officials deploy dual strategy against new mpox strain: ramped-up testing and easy vaccine access at local pharmacies and clinics.

Reuters

September 05, 2024

Youth E-Cigarette Use Plummeted in 2024

Youth e-cigarette use plummeted by 23.4% in 2024, with 500,000 fewer users compared to 2023, marking the lowest level in a decade and potentially signaling a shift in adolescent respiratory health trends.

Conexiant

September 03, 2024

Mobile Phones Not Linked to Brain Cancer

WHO and global health bodies called for re-evaluation of the 2011 cancer risk classification.

Reuters

September 03, 2024

U.S. Drug Prices Post-Negotiation: Still Double Global Rates

The U.S. government has negotiated lower prices for prescription drugs, but they are still considerably higher compared to other high-income countries. Will these negotiations eventually lead to more balanced drug pricing?

Reuters

August 30, 2024

Smallpox Vax for People at High Risk of Mpox Approved

FDA expands approval for smallpox vaccine to combat outbreak in Africa with Emergent BioSolutions' ACAM2000, as WHO declares global public health emergency.

Reuters

August 29, 2024

Under 30? ID Now Required for Cigarettes, Vapes

The FDA raises the minimum age for purchasing tobacco products, now requiring identification verification for individuals under 30 and prohibiting vending machine sales in the presence of individuals under 21.

Reuters